Prolactinoma in Women Who Are Pregnant or Desiring Pregnancy

Clinical Scenario

This protocol is for female patients with prolactinoma who are currently pregnant or who are planning to conceive. The clinical priority is to manage the prolactinoma while accounting for the safety of a developing pregnancy.

Patients in this situation should be informed of both medical and surgical treatment options before a management plan is agreed upon.

Treatment Approach

Medical treatment with dopamine agonist therapy is the recommended first-line approach, with specific guidance on how and when therapy is managed around the point of confirmed pregnancy.

The complete regimen — including drug selection, dosing decisions, and the full step-by-step protocol — is available in the structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1038/s41574-023-00886-5

Patients with prolactinoma considering pregnancy should be informed about both medical and surgical options (strong).
Most workshop participants recommended medical treatment with dopamine agonists as the first choice of therapy for women with prolactinoma desiring pregnancy.
To reduce exposure of the developing fetus to dopamine agonist therapy, dopamine agonists should be discontinued as soon as pregnancy is confirmed (strong).

View source ↗